VYNE Therapeutics Inc. reports

Company location: Bridgewater, NJ
Fiscal year end: 31 December

VYNE Therapeutics Inc. has filed 630 SEC EDGAR filings since 07 Jan 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 630 matching filings.

Per page

25

Current page

8

4

FORM 4 SUBMISSION

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38356

10-Q

Filing date: 11 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

8-K

Filing date: 11 May 2023
Reporting date: 11 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 01 May 2023
Reporting date: 28 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-38356

10-K

Filing date: 14 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

8-K

Filing date: 09 Mar 2023
Reporting date: 09 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 28 Feb 2023
Reporting date: 27 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 10 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 17 Jan 2023
Reporting date: 17 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 12 Jan 2023
Reporting date: 12 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jan 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jan 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jan 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jan 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Dec 2022
Reporting date: 30 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-38356

DEF 14A

Filing date: 25 Nov 2022
Reporting date: 12 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

D File 021-465372

D filing

Filing date: 18 Nov 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-38356

PRE 14A

Filing date: 14 Nov 2022
Reporting date: 12 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .